Packaging challenge for COVID-19 drug

Main Article Content

Anupam Chand

Article Details

Chand, A. (2020). Packaging challenge for COVID-19 drug. Archives of Biotechnology and Biomedicine, 4(1), 028–036. https://doi.org/10.29328/journal.abb.1001019
Review Articles

Copyright (c) 2020 Chand A.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

www.pda.org

www.glass-ts.com

www.sciencedirect.com

Highlights from June 2011 Glass Container Delamination Scientific Symposium. 2013. http://www.rx-360.org/LinkClick.aspx?

Swift, Rob Amgen presentations, PDA April 2011 San Antonio; PDA/FDA Glass Quality Conference May 2011.

http://www.fda.gov/Drugs/DrugSafety/ucm248490.htm

Ennis RD, Pritchard R, Nakamura C, Coulon M, Yang T, et al. Glass vials for small volume parenterals: influence of drug and manufacturing processes on glass delamination. Pharm Dev Tech. 2001; 6: 393-405. https://pubmed.ncbi.nlm.nih.gov/11485181/

Desmond H. USP Presentation, PDA/FDA Glass Quality Conference May 2013.

https://www.sciencedaily.com/releases/2020/09/200915152448.htm

https://youtu.be/FD0fhZB3bUE

https://investor.regeneron.com/static-files/a596a85e-e72d-4529-8eb5-d52d87a99070

https://www.businessinsider.com/regeneron-ceo-says-trump-antibody-drug-experience-weakest-evidence-success-2020-10

https://www.cbsnews.com/news/transcript-regeneron-ceo-leonard-schleifer-on-face-the-nation-october-11-2020/